524804:BOM
Aurobindo Pharma Ltd
1 658,65 ₹
arrow_downward
-0,98%(-16,35) 1K
16-okt, 15:30:00 (GMT+5:30) · INR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto524804 tikeri uchun statistika yaratilmoqda...
Ochish
1 683,55 ₹
Yuqori
1 683,55 ₹
Past
1 654,75 ₹
Bozor kapitali
959,10Â mlrd
Oʻrtacha hajm
29,66Â ming
Hajmi
11,19Â ming
P/E koeffitsiyenti
25,92
52 haftalik eng yuqori
1 739,95 ₹
52 haftalik eng past
1 080,10 ₹
Aksiya boʻyicha daromad
64,00 ₹
Muomaladagi aksiyalar
585,90Â mln
Xodimlar soni
29Â ming
Ochish
1 683,55 ₹
Yuqori
1 683,55 ₹
Past
1 654,75 ₹
Bozor kapitali
959,10Â mlrd
Oʻrtacha hajm
29,66Â ming
Hajmi
11,19Â ming
P/E koeffitsiyenti
25,92
52 haftalik eng yuqori
1 739,95 ₹
52 haftalik eng past
1 080,10 ₹
Aksiya boʻyicha daromad
64,00 ₹
Muomaladagi aksiyalar
585,90Â mln
Xodimlar soni
29Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Moneycontrol.com
·
2 kun oldin
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Profil
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Aurobindo Pharma Ltd haqida
CEO-
Xodimlar soni29,2Â ming
Asos solingan1986
Bosh ofislarHaydarobod, Andhra Pradesh, Hindiston
Sektor-
Veb-saytaurobindo.com